The European Medicines Agency (EMA) said on Wednesday that it has not received an application from the developers of Russia's Sputnik V coronavirus vaccine for market authorization in the European Union
MOSCOW (Pakistan Point News / Sputnik - 10th February, 2021) The European Medicines Agency (EMA) said on Wednesday that it has not received an application from the developers of Russia's Sputnik V coronavirus vaccine for market authorization in the European Union.
"The European Medicines Agency has to date not received an application for a rolling review or a marketing authorisation for the vaccine developed by the Gamaleya National Centre of Epidemiology and Microbiology in Russia, the Sputnik V vaccine (Gam-COVID-Vac), despite reports stating the opposite," a press release read.
The EMA said that the Gamaleya center had received scientific advice from the agency and added that discussions were ongoing.
